Therapeutic potential of the LHRH agonist, ICI 118630, in the treatment of advanced prostatic carcinoma. 1983

K J Walker, and R I Nicholson, and A O Turkes, and A Turkes, and K Griffiths, and M Robinson, and Z Crispin, and S Dris

8 patients with advanced prostatic carcinoma were treated with the luteinising-hormone releasing-hormone agonist, ICI 118630, for up to 3 months. Patients received subcutaneous injections of ICI 118630 (either 100 micrograms or 250 micrograms daily). At the higher dose level, plasma testosterone concentrations were significantly reduced by day 14 and approximated to those previously recorded in castrated or diethylstilboestrol-treated patients. Plasma concentrations of luteinising hormone and follicle-stimulating hormone were similarly reduced. Reduction in the dose, to 100 micrograms/day, similarly reduced plasma testosterone. ICI 118630 shows considerable potential for the management of patients with advanced carcinoma of the prostate.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D007987 Gonadotropin-Releasing Hormone A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND. FSH-Releasing Hormone,GnRH,Gonadoliberin,Gonadorelin,LH-FSH Releasing Hormone,LHRH,Luliberin,Luteinizing Hormone-Releasing Hormone,Cystorelin,Dirigestran,Factrel,Gn-RH,Gonadorelin Acetate,Gonadorelin Hydrochloride,Kryptocur,LFRH,LH-RH,LH-Releasing Hormone,LHFSH Releasing Hormone,LHFSHRH,FSH Releasing Hormone,Gonadotropin Releasing Hormone,LH FSH Releasing Hormone,LH Releasing Hormone,Luteinizing Hormone Releasing Hormone,Releasing Hormone, LHFSH
D008297 Male Males
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000135 Acid Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.2. Acid beta-Glycerophosphatase,Acid beta Glycerophosphatase
D013739 Testosterone A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. 17-beta-Hydroxy-4-Androsten-3-one,17-beta-Hydroxy-8 alpha-4-Androsten-3-one,8-Isotestosterone,AndroGel,Androderm,Andropatch,Androtop,Histerone,Sterotate,Sustanon,Testim,Testoderm,Testolin,Testopel,Testosterone Sulfate,17 beta Hydroxy 4 Androsten 3 one,17 beta Hydroxy 8 alpha 4 Androsten 3 one,8 Isotestosterone
D017273 Goserelin A synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE. Goserelin is used in treatments of malignant NEOPLASMS of the prostate, uterine fibromas, and metastatic breast cancer. Goserelin Acetate,ICI-118630,Zoladex,Acetate, Goserelin,ICI 118630,ICI118630

Related Publications

K J Walker, and R I Nicholson, and A O Turkes, and A Turkes, and K Griffiths, and M Robinson, and Z Crispin, and S Dris
August 1983, Lancet (London, England),
K J Walker, and R I Nicholson, and A O Turkes, and A Turkes, and K Griffiths, and M Robinson, and Z Crispin, and S Dris
January 1989, Minerva urologica e nefrologica = The Italian journal of urology and nephrology,
K J Walker, and R I Nicholson, and A O Turkes, and A Turkes, and K Griffiths, and M Robinson, and Z Crispin, and S Dris
November 1984, The Journal of endocrinology,
K J Walker, and R I Nicholson, and A O Turkes, and A Turkes, and K Griffiths, and M Robinson, and Z Crispin, and S Dris
October 1986, Hinyokika kiyo. Acta urologica Japonica,
K J Walker, and R I Nicholson, and A O Turkes, and A Turkes, and K Griffiths, and M Robinson, and Z Crispin, and S Dris
October 1984, Harefuah,
K J Walker, and R I Nicholson, and A O Turkes, and A Turkes, and K Griffiths, and M Robinson, and Z Crispin, and S Dris
January 1985, British medical journal (Clinical research ed.),
K J Walker, and R I Nicholson, and A O Turkes, and A Turkes, and K Griffiths, and M Robinson, and Z Crispin, and S Dris
September 1988, Harefuah,
K J Walker, and R I Nicholson, and A O Turkes, and A Turkes, and K Griffiths, and M Robinson, and Z Crispin, and S Dris
March 1986, Hinyokika kiyo. Acta urologica Japonica,
K J Walker, and R I Nicholson, and A O Turkes, and A Turkes, and K Griffiths, and M Robinson, and Z Crispin, and S Dris
January 1987, The Journal of urology,
K J Walker, and R I Nicholson, and A O Turkes, and A Turkes, and K Griffiths, and M Robinson, and Z Crispin, and S Dris
May 1987, British journal of urology,
Copied contents to your clipboard!